La. Rev. Stat. § 22:1060.13
Prior authorization; time periods
Louisiana · Louisiana Revised Statutes Title 22 — Insurance · Status: effective
Cite this
- Citation
- La. Rev. Stat. § 22:1060.13, Prior authorization; time periods, Louisiana, version 1 as recorded 2026-10-04, yourstate.us, https://yourstate.us/provision/2704672
- Permanent ID
ys:prov:2704672@1- SHA-256
95784761e683bc53accdf55794069e3d8bbc333b7f3819a386690be2019a3d98
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
A. For any services typically covered under the plan and related to the diagnosis or treatment of cancer for which prior authorization is required under a health coverage plan, the health insurance issuer shall offer an expedited review to the provider requesting prior authorization. The health insurance issuer shall communicate its decision on the prior authorization request to the provider as soon as possible, but in all cases no later than two business days from the receipt of the request for expedited review. If additional information is needed and requested for the issuer to make its determination, the issuer shall communicate its decision to the provider as soon as possible, but no later than forty-eight hours from receipt of the additional information.
B. For any services typically covered under the plan and related to the diagnosis or treatment of cancer for which prior authorization is required under a health coverage plan and for which the health insurance issuer does not receive a request for expedited review from the provider, the issuer shall communicate its decision on the prior authorization request no later than five days from the receipt of the request. If additional information is needed and requested for the issuer to make its determination, the issuer shall communicate its decision to the provider no more than two business days from receipt of the additional information.
C. The provisions of this Section shall apply only when the requesting provider clearly indicated that the request is related to the diagnosis or treatment of cancer.
D. The provisions of this Section shall not apply to non-melanomatous skin cancer.